Slingshot members are tracking this event:

AstraZeneca Phase 3 PACIFIC trial—evaluating durvalumab in efficacy for lung cancer—set for data readout in the second half of 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pacific Trial, Durvalumab, Lung Cancer, Phase 3